COHERUS BIOSCIENCES INC (CHRS) Institutional Shareholders
COHERUS BIOSCIENCES INC (CHRS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $80.18M in CHRS holdings during the latest filing period.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of CHRS tracked by InsiderSet, reporting ownership valued at approximately $16.80M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $16.20M, representing an estimated loss of -3.57% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed CHRS value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Vanguard Capital Management Llc, Geode Capital Management, Llc, and several other long-term asset managers with concentrated positions in COHERUS BIOSCIENCES INC (CHRS).
This page ranks the largest institutional CHRS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
142
Total Reported Value
$80.18M
Largest Holder
Blackrock, Inc.
Largest Position
$16.80M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
119
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 12,003,316 | $16,804,642 | $16,204,477 | -$600,165 | -3.57% | |
| Vanguard Capital Management Llc | 0.00% | 5,949,490 | $8,329,286 | $8,031,812 | -$297,474 | -3.57% | |
| Geode Capital Management, Llc | 0.00% | 3,685,567 | $5,161,010 | $4,975,515 | -$185,495 | -3.59% | |
| Samsara Biocapital, Llc | 0.39% | 3,428,571 | $4,799,999 | $4,628,571 | -$171,428 | -3.57% | |
| Kohlberg Kravis Roberts & Co. L.P. | 0.07% | 3,036,076 | $4,184,019 | $4,098,703 | -$85,316 | -2.04% | |
| State Street Corp | 0.00% | 2,382,305 | $3,335,227 | $3,216,112 | -$119,115 | -3.57% | |
| Two Sigma Investments, Lp | 0.00% | 2,259,412 | $3,163,177 | $3,050,206 | -$112,971 | -3.57% | |
| Cm Management, Llc | 1.87% | 2,100,000 | $2,940,000 | $2,835,000 | -$105,000 | -3.57% | |
| C Worldwide Group Holding A/S | 0.07% | 1,928,464 | $2,700,000 | $2,603,426 | -$96,574 | -3.58% | |
| Alyeska Investment Group, L.P. | 0.01% | 1,733,234 | $2,426,528 | $2,339,866 | -$86,662 | -3.57% | |
| Hudson Bay Capital Management Lp | 0.01% | 1,693,000 | $2,370,200 | $2,285,550 | -$84,650 | -3.57% | |
| Aqr Capital Management Llc | 0.00% | 1,330,201 | $1,862,281 | $1,795,771 | -$66,510 | -3.57% | |
| Charles Schwab Investment Management Inc | 0.00% | 1,228,069 | $1,719,297 | $1,657,893 | -$61,404 | -3.57% | |
| Panagora Asset Management Inc | 0.00% | 1,137,325 | $1,592,255 | $1,535,389 | -$56,866 | -3.57% | |
| Northern Trust Corp | 0.00% | 1,129,470 | $1,581,259 | $1,524,785 | -$56,475 | -3.57% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,015,991 | $1,422,387 | $1,371,588 | -$50,799 | -3.57% | |
| Nomura Asset Management International Inc. | 0.00% | 899,999 | $1,260,000 | $1,214,999 | -$45,001 | -3.57% | |
| Vanguard Portfolio Management Llc | 0.00% | 883,454 | $1,236,836 | $1,192,663 | -$44,173 | -3.57% | |
| Ubs Group Ag | 0.00% | 760,358 | $1,064,501 | $1,026,483 | -$38,018 | -3.57% | |
| Goldman Sachs Group Inc | 0.00% | 602,075 | $842,905 | $812,801 | -$30,104 | -3.57% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 563,056 | $788,278 | $760,126 | -$28,152 | -3.57% |
| Strs Ohio | 0.00% | 395,600 | $553,840 | $534,060 | -$19,780 | -3.57% | |
| Bridgeway Capital Management, Llc | 0.01% | 391,000 | $547,400 | $527,850 | -$19,550 | -3.57% | |
| Gsa Capital Partners Llp | 0.03% | 379,355 | $531,000 | $512,129 | -$18,871 | -3.55% | |
| Invesco Ltd. | 0.00% | 353,922 | $495,491 | $477,795 | -$17,696 | -3.57% | |
| Bank Of New York Mellon Corp | 0.00% | 319,687 | $447,563 | $431,577 | -$15,986 | -3.57% | |
| Bank Of America Corp | 0.00% | 302,528 | $423,540 | $408,413 | -$15,127 | -3.57% | |
| Alliancebernstein L.P. | 0.00% | 221,900 | $375,011 | $299,565 | -$75,446 | -20.12% | |
| Jefferies Financial Group Inc. | 0.00% | 252,000 | $352,800 | $340,200 | -$12,600 | -3.57% | |
| Nuveen, Llc | 0.00% | 250,749 | $351,049 | $338,511 | -$12,538 | -3.57% | |
| Morgan Stanley | 0.00% | 230,748 | $323,048 | $311,510 | -$11,538 | -3.57% | |
| Tyche Wealth Partners Llc | 0.04% | 201,202 | $281,683 | $271,623 | -$10,060 | -3.57% | |
| Barclays Plc | 0.00% | 201,143 | $281,601 | $271,543 | -$10,058 | -3.57% | |
| Ieq Capital, Llc | 0.00% | 162,353 | $227,294 | $219,177 | -$8,117 | -3.57% | |
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 0.00% | 159,990 | $223,986 | $215,987 | -$8,000 | -3.57% | |
| Acadian Asset Management Llc | 0.00% | 149,227 | $207,000 | $201,456 | -$5,544 | -2.68% | |
| Rhumbline Advisers | 0.00% | 142,361 | $199,296 | $192,187 | -$7,109 | -3.57% | |
| Envestnet Asset Management Inc | 0.00% | 140,870 | $197,218 | $190,175 | -$7,044 | -3.57% | |
| Pvg Asset Management Corp | 0.11% | 133,235 | $186,529 | $179,867 | -$6,662 | -3.57% | |
| Deutsche Bank Ag\ | 0.00% | 127,621 | $178,669 | $172,288 | -$6,381 | -3.57% | |
| Xtx Topco Ltd | 0.00% | 123,497 | $172,896 | $166,721 | -$6,175 | -3.57% | |
| Summit Financial, Llc | 0.00% | 114,861 | $160,805 | $155,062 | -$5,743 | -3.57% | |
| Wells Fargo & Company/Mn | 0.00% | 112,903 | $158,064 | $152,419 | -$5,645 | -3.57% | |
| Susquehanna International Group, Llp | 0.00% | 109,627 | $153,478 | $147,996 | -$5,482 | -3.57% | |
| Price T Rowe Associates Inc | 0.00% | 108,750 | $153,000 | $146,813 | -$6,188 | -4.04% | |
| Shay Capital Llc | 0.02% | 105,326 | $147,456 | $142,190 | -$5,266 | -3.57% | |
| Corient Private Wealth Llc | 0.00% | 100,000 | $140,000 | $135,000 | -$5,000 | -3.57% | |
| Hsbc Holdings Plc | 0.00% | 91,895 | $130,950 | $124,058 | -$6,892 | -5.26% | |
| Cwm, Llc | 0.00% | 70,341 | $118,876 | $94,960 | -$23,916 | -20.12% | |
| Metlife Investment Management, Llc | 0.00% | 78,613 | $110,058 | $106,128 | -$3,930 | -3.57% |
Frequently asked questions about CHRS
Who owns the most CHRS stock?
The largest holders of CHRS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for COHERUS BIOSCIENCES INC (CHRS).
Is CHRS widely held by superinvestors?
Many widely followed stocks like CHRS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly CHRS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.